0000950170-25-013670.txt : 20250204 0000950170-25-013670.hdr.sgml : 20250204 20250204170119 ACCESSION NUMBER: 0000950170-25-013670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250203 FILED AS OF DATE: 20250204 DATE AS OF CHANGE: 20250204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Narula Sanjeev CENTRAL INDEX KEY: 0001820590 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 25589337 MAIL ADDRESS: STREET 1: C/O INTRA-CELLULAR THERAPIES, INC. STREET 2: 135 ROUTE 202/206 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 ROUTE 202/206 STREET 2: SUITE 6 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (646) 440-9333 MAIL ADDRESS: STREET 1: 135 ROUTE 202/206 STREET 2: SUITE 6 CITY: BEDMINSTER STATE: NJ ZIP: 07921 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 4 1 ownership.xml 4 X0508 4 2025-02-03 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001820590 Narula Sanjeev C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206, SUITE 6 BEDMINSTER NJ 07921 false true false false Executive Vice President & CFO false Restricted Stock Units 2025-02-03 4 A false 22727 0 A Common Stock 22727 22727 D Each restricted stock unit represents a contingent right to receive one share of common stock. On February 3, 2025, the reporting person was granted 22,727 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. /s/ John P. Condon, Attorney-in-fact 2025-02-04